Drugs that could combat ageing and help people to live up to 150 years may be available within the next five years, a new landmark research suggests.
The study proves that a single anti-aging enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans. The research, published in the journal Science, shows all of the 117 drugs tested work on the single enzyme through a common mechanism. This means that a whole new class of anti-aging drugs is now viable, which could ultimately prevent cancer, Alzheimer's disease and type 2 diabetes.
‘Ultimately, these drugs would slow down ageing’, said David Sinclair, from the University of New South Wales (UNSW) Medicine.
The study proves that a single anti-aging enzyme in the body can be targeted, with the potential to prevent age-related diseases and extend lifespans. The research, published in the journal Science, shows all of the 117 drugs tested work on the single enzyme through a common mechanism. This means that a whole new class of anti-aging drugs is now viable, which could ultimately prevent cancer, Alzheimer's disease and type 2 diabetes.
‘Ultimately, these drugs would slow down ageing’, said David Sinclair, from the University of New South Wales (UNSW) Medicine.